2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Cyclophosphamide
64
Tacrolimus
55
Methotrexate
46
Mycophenolic Acid
39
Cyclosporine
37
fludarabine phosphate
35
Busulfan
35
Antilymphocyte Serum
32
fludarabine
29
Sirolimus
26
Melphalan
23
Peripheral Blood Stem Cell Transplantation
22
Radiotherapy
21
Methylprednisolone
21
Whole-Body Irradiation
19
Filgrastim
17
thymoglobulin
14
Thiotepa
11
Stem Cell Transplantation
10
Rituximab
10
ruxolitinib
9
Granulocyte Colony-Stimulating Factor
9
Prednisone
7
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Alemtuzumab
7
Transplantation
6
Pentostatin
6
Cytarabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
trihexyltetradecylphosphonium chloride
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled